Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
Phase 3
Completed
- Conditions
- Osteoarthritis
- Registration Number
- NCT00092703
- Lead Sponsor
- Organon and Co
- Brief Summary
The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.
- Detailed Description
The duration of treatment is 12 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
- Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief
Exclusion Criteria
- Known allergies to the study drugs
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Discontinuations due to clinical and laboratory gastrointestinal adverse experiences during a 1 year treatment period.
- Secondary Outcome Measures
Name Time Method